Treatment with ursolic acid inhibits TNFα-induced NF-κB activation and the STAT3 signal pathway, resulting in decreased PCa cell proliferation in vitro and xenograft tumor growth in animal models [32]. The gene discussed is NFKB1; the disease is posterior cortical atrophy.